Category: Access campaign

MSF: Game-changing HIV prevention medicine must be available for $40 per year, everywhere 
MSF: Game-changing HIV prevention medicine must be available for $40 per year, everywhere 
MSF wants to buy groundbreaking HIV prevention drug. Why won’t Gilead sell?
Governments must take concrete actions to ensure equitable access to medical tools for noncommunicable diseases and mental health conditions
Governments must take concrete actions to ensure equitable access to medical tools for noncommunicable diseases and mental health conditions
Central African Republic: Living with Diabetes in Carnot
Central African Republic: Living with Diabetes in Carnot
MSF launches a large hepatitis C “test and treat” campaign amid critical lack of treatment options
Bangladesh: MSF launches a large hepatitis C “test and treat” campaign amid critical lack of treatment options
Migrating while managing diabetes: why access to insulin in pens must be available to everyone
MSF and global TB activists take stage at annual TB conference
Ahead of World Diabetes Day, pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi must make insulin pens available at $1 per pen
Addressing Healthcare Challenges for PLHIV in Patna
India: Addressing Healthcare Challenges for people living with HIV in Patna
Activists at AIDS2024 demand: Break Gilead’s Lenacapavir monopoly